Since the beginning of this year, the enthusiasm of listed pharmaceutical companies to buy back has been very high, and many companies have issued repurchase plans
.
Data shows that as of October 17, Hong Kong-listed companies have repurchased HK$73 billion during the year, nearly double the total amount of repurchases in 2021 and a record high
.
Among them, from the overall point of view, listed companies in the pharmaceutical sector are undoubtedly "regulars"
on the repurchase list.
On December 2, Hengrui Pharmaceutical announced that as of November 30, the company had repurchased a total of 12 million shares through centralized bidding transactions, accounting for 0.
19% of the company's total share capital, the highest price of the transaction was 34.
9 yuan / share, the lowest price was 27.
08 yuan / share, and the total amount paid was 398 million yuan (excluding transaction fees).
On the same day, Hotjing Biotech also announced that as of the close of November 30, 2022, the company had repurchased a total of 2.
5186 million shares of the company through the Shanghai Stock Exchange trading system in a centralized bidding transaction, accounting for 2.
7362% of the company's total share capital of 92.
0505 million shares, the highest price of the repurchase transaction was 93 yuan / share, the lowest price was 51.
78 yuan / share, and the total amount of funds paid was 150 million yuan (excluding stamp duty, transaction commissions and other transaction
。
On December 1, CanSino announced that as of November 30, the company had repurchased a total of 670,100 A shares in a centralized bidding transaction, accounting for 0.
2708% of the company's total share capital, with the highest transaction price of 269.
07 yuan / share, the lowest transaction price of 158.
00 yuan / share, and the total transaction amount of 147 million yuan (excluding transaction fees such as transaction commission fees).
In addition, Antu Biotech announced that as of November 30, 2022, the company has repurchased a total of 5.
2609 million shares through centralized bidding transactions, accounting for 0.
9% of the company's total share capital, the highest transaction price is 49.
92 yuan / share, the lowest price is 42.
32 yuan / share, and the total amount paid is 243 million yuan (excluding transaction fees).
The above repurchase complies with the provisions of relevant laws and regulations and the requirements of
the company's repurchase program.
It is worth mentioning that from September 30 to October 25, WuXi Biologics has continued to repurchase a total of 50.
72 million shares, accounting for about 1.
2% of the issued shares, at a cost of HK$
2.
328 billion.
On September 26, WuXi Biologics announced its intention to repurchase shares
on the open market for a total price of up to US$300 million.
Previously, from December 2021 to January this year, WuXi Biologics had spent HK$3.
92 billion on repurchases
.
In general, the repurchase of pharmaceutical companies has become the norm in the industry, since the beginning of 2022, the top domestic pharmaceutical listed companies have accelerated the pace of repurchase, and earlier industry analysts pointed out that more than 30 pharmaceutical companies announced share repurchase plans and repurchase progress
in the first quarter of 2022 alone.
In this regard, analysts believe that the repurchase of shares will help to continuously enhance investors' confidence in the company, safeguard the interests of the majority of investors, establish and improve the company's long-term incentive mechanism, fully mobilize the enthusiasm of staff, and promote the company's healthier, more stable and long-term development
.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
